Janbernd Kirschner
Consultant Pediatric Neurologist
Germany
Dr. Jan Kirschner is coordinator of the TREAT-NMD Clinical Trial Coordination Centre (CTCC) based in Freiburg, Germany. Jan has been joint coordinator of the German network for neuromuscular disorders MD-NET (www.md-net.org) since 2008. He has been involved in planning and conducting several multicentre clinical trials. He was responsible for the coordination of a large multi-centre, placebo-controlled MD-NET trial in Duchenne muscular dystrophy. With the CTCC team in Freiburg Jan has established the Care and Trial Site Registry (CTSR) containing feasibility information about neuromuscular centres worldwide.
Jan is coordinator of the CARE-NMD project funded by the European Union since 2010 with the aim to improve standard of care for Duchenne muscular dystrophy throughout Europe (www.care-nmd.eu). He has a long-standing interest in the diagnosis and treatment of myopathies and muscular dystrophies in children and is head of the neuromuscular laboratory at Freiburg University. Current areas of research activities include the pathogenesis of muscular dystrophies and clinical trials in neurmuscular disorders.
Organisations
University Medical Center Freiburg

The TREAT-NMD Clinical Trials Coordination Centre (CTCC) has been set up to work with pharmaceutical companies to facilitate every aspect of the trial …
Committees
TREAT-NMD Ethics Board – TEB
The TREAT-NMD Ethics Board identifies and examines ethical and social aspects of research taking place in the context of TREAT-NMD.
TREAT-NMD Task-Force
An academic task force consisting of key clinical and scientific experts from around the world has been established to help develop the future focus a …

Country
